NIH Renews Charter for Cancer Trials Advisory Group
Published Date: 3/24/2026
Notice
Summary
The National Cancer Institute’s Clinical Trials and Translational Research Advisory Committee (CTAC) is getting its charter renewed for two more years starting April 14, 2026. This group helps guide important cancer research, and the renewal keeps their work going with a budget of about $121,000 for the year. The renewal affects committee members and supports ongoing advice to improve cancer clinical trials without any major changes or new costs.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in